Cargando…
Thrombocytopenia: A possible side effect of apixaban
Apixaban is becoming more frequently prescribed for stroke prevention in patients with atrial fibrillation, and even rare side effects such as thrombocytopenia should be considered and monitored closely.
Autor principal: | Sadaka, Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935631/ https://www.ncbi.nlm.nih.gov/pubmed/31893097 http://dx.doi.org/10.1002/ccr3.2532 |
Ejemplares similares
-
Case report: apixaban‐induced thrombocytopenia
por: Snellgrove, Oliver
Publicado: (2017) -
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020) -
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
por: Ezekwudo, Daniel E., et al.
Publicado: (2017) -
A rare side effect seen due to the use of apixaban: Palmoplantar psoriasiform drug eruption
por: Veliyev, Vusal, et al.
Publicado: (2016) -
Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
por: Larsen, Pia Bükmann, et al.
Publicado: (2015)